title: The intrauterine contraceptive device.
abstract: The intrinsic appeal of the convenience and effectiveness of the IUD has increased interest in these devices in the United States in recent years. Understanding the uniqueness of the Dalkon Shield experience and applying the lessons learned about appropriate candidate selection should continue to reduce any lingering liability concerns. One lawsuit has been filed against the copper IUD in the 12 years that it has been available in the United States. If legislation requiring insurance coverage for IUDs and other prescription contraceptive agents continues to be passed by more states, the use of IUDs will continue to grow. The introduction of new IUDs with different side-effect profiles will expand the number of US women who can and will be interested in using this method of birth control.
authors.affiliation: Department of Obstetrics and Gynecology, University of California Los Angeles School of Medicine, USA. AnitaNelsonWHC@earthlink.net
authors.forename: A L
authors.initials: AL
authors.lastname: Nelson
mesh_terms: D003362:Cost-Benefit Analysis; D005260:Female; D049673:History, 20th Century; D006801:Humans; D007239:Infections / Q000209:etiology; D007434:Intrauterine Devices / Q000009:adverse effects / Q000191:economics / Q000266:history; D007435:Intrauterine Devices, Copper; D018579:Patient Selection; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage; D012307:Risk Factors; D014481:United States; D014592:Uterine Hemorrhage / Q000209:etiology
chemical_list: D011374:Progesterone